Home LiteratureArticle Details
PMID: 24990952 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

The Journal of biological chemistry ·Vol. 289 ·No. 33 ·2014-08-15 ·Pages 22583-22588

Foster DA, Salloum D, Menon D, Frias MA

Abstract

Phosphatidic acid (PA) is a critical metabolite at the heart of membrane phospholipid biosynthesis. However, PA also serves as a critical lipid second messenger that regulates several proteins implicated in the control of cell cycle progression and cell growth. Three major metabolic pathways generate PA: phospholipase D (PLD), diacylglycerol kinase (DGK), and lysophosphatidic acid acyltransferase (LPAAT). The LPAAT pathway is integral to de novo membrane phospholipid biosynthesis, whereas the PLD and DGK pathways are activated in response to growth factors and stress. The PLD pathway is also responsive to nutrients. A key target for the lipid second messenger function of PA is mTOR, the mammalian/mechanistic target of rapamycin, which integrates both nutrient and growth factor signals to control cell growth and proliferation. Although PLD has been widely implicated in the generation of PA needed for mTOR activation, it is becoming clear that PA generated via the LPAAT and DGK pathways is also involved in the regulation of mTOR. In this minireview, we highlight the coordinated maintenance of intracellular PA levels that regulate mTOR signals stimulated by growth factors and nutrients, including amino acids, lipids, glucose, and Gln. Emerging evidence indicates compensatory increases in one source of PA when another source is compromised, highlighting the importance of being able to adapt to stressful conditions that interfere with PA production. The regulation of PA levels has important implications for cancer cells that depend on PA and mTOR activity for survival.

Keywords
Diacylglycerol Kinase Lipid Metabolism Lysophosphatidic Acid Acyltransferase Mammalian Target of Rapamycin (mTOR) Phosphatidic Acid Phospholipase D glycolysis
MeSH Terms
1-Acylglycerol-3-Phosphate O-Acyltransferase/genetics,metabolism Animals Diacylglycerol Kinase/genetics,metabolism Glucose/genetics,metabolism Glutamine/genetics,metabolism Humans Phosphatidic Acids/genetics,metabolism Phospholipase D/genetics,metabolism Second Messenger Systems/physiology TOR Serine-Threonine Kinases/genetics,metabolism
Chemicals
Phosphatidic Acids Glutamine 1-Acylglycerol-3-Phosphate O-Acyltransferase MTOR protein, human Diacylglycerol Kinase TOR Serine-Threonine Kinases Phospholipase D Glucose
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Foster David A
Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065. Electronic address: foster@genectr.hunter.cuny.edu.
Salloum Darin
Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Menon Deepak
Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
Frias Maria A
Department of Biological Sciences, Hunter College of the City University of New York, New York, New York 10065.
References (71)
71 references, click to expand
  1. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
    Mol Cell Biol. 2004 Jan;24(1):200-16 PMID: 14673156
  2. The phospholipase D1 pathway modulates macroautophagy.
    Nat Commun. 2010;1:142 PMID: 21266992
  3. Glutamine and cancer: cell biology, physiology, and clinical opportunities.
    J Clin Invest. 2013 Sep;123(9):3678-84 PMID: 23999442
  4. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
    Cancer Discov. 2013 Jul;3(7):782-97 PMID: 23558954
  5. What is the restriction point?
    Curr Opin Cell Biol. 1995 Dec;7(6):835-42 PMID: 8608014
  6. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.
    Cell. 2010 Apr 16;141(2):290-303 PMID: 20381137
  7. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.
    Mol Cell Biol. 2004 Nov;24(21):9508-16 PMID: 15485918
  8. Regulation of TOR by small GTPases.
    EMBO Rep. 2012 Feb 01;13(2):121-8 PMID: 22240970
  9. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
    Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1667-72 PMID: 22307628
  10. Induction of phosphatidic acid by fibroblast growth factor in cultured baby hamster kidney fibroblasts.
    FEBS Lett. 1993 Oct 11;332(1-2):164-8 PMID: 8405435
  11. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.
    Clin Cancer Res. 2008 Jul 1;14(13):4267-74 PMID: 18594009
  12. The role of phospholipids in the biological activity and structure of the endoplasmic reticulum.
    Biochim Biophys Acta. 2013 Nov;1833(11):2499-510 PMID: 23711956
  13. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.
    Oncogene. 2010 Jan 21;29(3):313-24 PMID: 19881548
  14. v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine.
    Mol Cell Biol. 1991 Oct;11(10):4903-8 PMID: 1656217
  15. Regulation of mTOR by phosphatidic acid?
    Cancer Res. 2007 Jan 1;67(1):1-4 PMID: 17210675
  16. Insulin stimulates phospholipase D-dependent phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes.
    Endocrinology. 1996 Jul;137(7):3014-20 PMID: 8770926
  17. Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D.
    Biochem J. 1991 Oct 15;279 ( Pt 2):559-65 PMID: 1659382
  18. Molecular damage in cancer: an argument for mTOR-driven aging.
    Aging (Albany NY). 2011 Dec;3(12):1130-41 PMID: 22246147
  19. Redundant functions of phospholipases D1 and D2 in platelet α-granule release.
    J Thromb Haemost. 2012 Nov;10(11):2361-72 PMID: 22974101
  20. Albumin as fatty acid transporter.
    Drug Metab Pharmacokinet. 2009;24(4):300-7 PMID: 19745557
  21. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.
    Mol Cell. 2010 Oct 22;40(2):310-22 PMID: 20965424
  22. Ras mediates the activation of phospholipase D by v-Src.
    J Biol Chem. 1995 Mar 17;270(11):6006-9 PMID: 7890731
  23. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
    Dev Cell. 2006 Dec;11(6):859-71 PMID: 17141160
  24. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells.
    Biochem J. 2003 Jan 15;369(Pt 2):363-8 PMID: 12385647
  25. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
    Biochim Biophys Acta. 2009 Sep;1791(9):949-55 PMID: 19264150
  26. Protein kinase C, an elusive therapeutic target?
    Nat Rev Drug Discov. 2012 Dec;11(12):937-57 PMID: 23197040
  27. The hydrophobic amino acids involved in the interdomain association of phospholipase D1 regulate the shuttling of phospholipase D1 from vesicular organelles into the nucleus.
    Exp Mol Med. 2012 Oct 31;44(10):571-7 PMID: 22824913
  28. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.
    Cancer Cell. 2012 Mar 20;21(3):297-308 PMID: 22439925
  29. PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation.
    Mol Cell Biol. 2012 Jun;32(12):2268-78 PMID: 22493067
  30. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival.
    FASEB J. 2004 Apr;18(6):627-36 PMID: 15054085
  31. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50 PMID: 18032601
  32. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.
    Cell Metab. 2008 Jan;7(1):11-20 PMID: 18177721
  33. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases.
    Biochim Biophys Acta. 2009 Sep;1791(9):956-61 PMID: 19250975
  34. Phospholipase D1 is an effector of Rheb in the mTOR pathway.
    Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91 PMID: 18550814
  35. Phosphatidic acid-mediated mitogenic activation of mTOR signaling.
    Science. 2001 Nov 30;294(5548):1942-5 PMID: 11729323
  36. Phosphatidic acid plays a regulatory role in clathrin-mediated endocytosis.
    Mol Biol Cell. 2010 Aug 15;21(16):2944-52 PMID: 20573978
  37. Phospholipase D couples survival and migration signals in stress response of human cancer cells.
    J Biol Chem. 2006 Jun 9;281(23):15862-8 PMID: 16595654
  38. Phosphatidate phosphatase, a key regulator of lipid homeostasis.
    Biochim Biophys Acta. 2013 Mar;1831(3):514-22 PMID: 22910056
  39. Phosphatidic acid and lipid-sensing by mTOR.
    Trends Endocrinol Metab. 2013 Jun;24(6):272-8 PMID: 23507202
  40. Phosphatidic acid, a key intermediate in lipid metabolism.
    Eur J Biochem. 1999 Nov;266(1):1-16 PMID: 10542045
  41. Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway.
    J Biochem Mol Biol. 2006 Sep 30;39(5):626-35 PMID: 17002884
  42. Phospholipase D in cell proliferation and cancer.
    Mol Cancer Res. 2003 Sep;1(11):789-800 PMID: 14517341
  43. Acyl-CoA:lysophospholipid acyltransferases.
    J Biol Chem. 2009 Jan 2;284(1):1-5 PMID: 18718904
  44. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.
    Genes Dev. 2013 May 15;27(10):1115-31 PMID: 23699409
  45. Enrichment of phosphatidylinositols with specific acyl chains.
    Biochim Biophys Acta. 2014 Jun;1838(6):1501-8 PMID: 24120446
  46. Target of rapamycin (TOR) in nutrient signaling and growth control.
    Genetics. 2011 Dec;189(4):1177-201 PMID: 22174183
  47. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
    Science. 2008 Jun 13;320(5882):1496-501 PMID: 18497260
  48. Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.
    Mol Cancer Ther. 2014 Mar;13(3):733-41 PMID: 24435447
  49. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
    Cancer. 2006 Oct 1;107(7):1511-9 PMID: 16944535
  50. Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).
    Genes Cancer. 2010 Nov;1(11):1124-31 PMID: 21779436
  51. Ras-superfamily GTP-ases in ovarian cancer.
    Cancer Treat Res. 2009;149:229-40 PMID: 19763439
  52. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
    Biochem Biophys Res Commun. 1999 Feb 16;255(2):502-7 PMID: 10049738
  53. Phospholipase D and mTORC1: nutrients are what bring them together.
    Sci Signal. 2012 Mar 27;5(217):pe13 PMID: 22457329
  54. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
    Cancer Lett. 2007 Dec 18;258(2):268-75 PMID: 17949898
  55. Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells.
    Mol Cancer Ther. 2003 Oct;2(10):1067-78 PMID: 14578472
  56. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).
    J Biol Chem. 2011 Jul 22;286(29):25477-86 PMID: 21622984
  57. Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid.
    J Biol Chem. 2005 Mar 18;280(11):10091-9 PMID: 15632115
  58. Phosphatidylcholine-specific phospholipase D activity is elevated in v-Fps-transformed cells.
    Biochem Biophys Res Commun. 1994 Sep 15;203(2):1195-2003 PMID: 8093039
  59. Amino acids and mTORC1: from lysosomes to disease.
    Trends Mol Med. 2012 Sep;18(9):524-33 PMID: 22749019
  60. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
    Nature. 2013 May 30;497(7451):633-7 PMID: 23665962
  61. mTOR: from growth signal integration to cancer, diabetes and ageing.
    Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35 PMID: 21157483
  62. Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway.
    J Cell Biol. 2011 Oct 31;195(3):435-47 PMID: 22024166
  63. Diacylglycerol kinases: at the hub of cell signalling.
    Biochem J. 2008 Jan 1;409(1):1-18 PMID: 18062770
  64. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins.
    Science. 1986 Sep 5;233(4768):1061-8 PMID: 3090687
  65. Role of phosphatidic acid in the coupling of the ERK cascade.
    J Biol Chem. 2008 Dec 26;283(52):36636-45 PMID: 18952605
  66. Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle.
    PLoS One. 2013 Aug 19;8(8):e74157 PMID: 23977397
  67. Coupled inositide phosphorylation and phospholipase D activation initiates clathrin-coat assembly on lysosomes.
    J Biol Chem. 1999 Jun 18;274(25):17794-805 PMID: 10364223
  68. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
    Mol Cell Biol. 2009 Mar;29(6):1411-20 PMID: 19114562
  69. Epidermal growth factor induces the production of biologically distinguishable diglyceride species from phosphatidylinositol and phosphatidylcholine via the independent activation of type C and type D phospholipases.
    Cell Growth Differ. 1994 Jan;5(1):79-85 PMID: 8123595
  70. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids.
    Proc Natl Acad Sci U S A. 2013 May 28;110(22):8882-7 PMID: 23671091
  71. Lysophosphatidic acid acyltransferase beta regulates mTOR signaling.
    PLoS One. 2013 Oct 31;8(10):e78632 PMID: 24205284
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2014-08-15
Epub
2014-00-02
Pages
22583-22588
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC4132766
Subset
IM
Grants
NCI NIH HHS · R01 CA046677 · United States
NCRR NIH HHS · RR-03039 · United States
NCI NIH HHS · 1R01-CA046677 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com